Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

Owen A. Ross; Yih Ru Wu; Mei Ching Lee; Manabu Funayama; Meng Ling Chen; Alexandra I. Soto; Ignacio F. Mata; Guey Jen Lee-Chen; Mei Chen Chiung; Michelle Tang; Yi Zhao; Nobutaka Hattori; Matthew J. Farrer; Eng King Tan; Ruey Meei Wu

doi:10.1002/ana.21405

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

Owen A. Ross
, Yih Ru Wu^*
, Mei Ching Lee
, Manabu Funayama
, Meng Ling Chen
, Alexandra I. Soto
, Ignacio F. Mata
, Guey Jen Lee-Chen
, Mei Chen Chiung
, Michelle Tang
, Yi Zhao
, Nobutaka Hattori
, Matthew J. Farrer
, Eng King Tan
, Ruey Meei Wu

^*Corresponding author for this work

Department of Life Science

Research output: Contribution to journal › Article › peer-review

174 Citations (Scopus)

Abstract

Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LKRK2 variants in sporadic Parkinson's disease.

Original language	English
Pages (from-to)	88-92
Number of pages	5
Journal	Annals of Neurology
Volume	64
Issue number	1
DOIs	https://doi.org/10.1002/ana.21405
Publication status	Published - 2008 Jul

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1002/ana.21405

Cite this

@article{71366919c00a452498315082c7009394,

title = "Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease",

abstract = "Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95\% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LKRK2 variants in sporadic Parkinson's disease.",

author = "Ross, \{Owen A.\} and Wu, \{Yih Ru\} and Lee, \{Mei Ching\} and Manabu Funayama and Chen, \{Meng Ling\} and Soto, \{Alexandra I.\} and Mata, \{Ignacio F.\} and Lee-Chen, \{Guey Jen\} and Chiung, \{Mei Chen\} and Michelle Tang and Yi Zhao and Nobutaka Hattori and Farrer, \{Matthew J.\} and Tan, \{Eng King\} and Wu, \{Ruey Meei\}",

year = "2008",

month = jul,

doi = "10.1002/ana.21405",

language = "English",

volume = "64",

pages = "88--92",

journal = "Annals of Neurology",

issn = "0364-5134",

publisher = "John Wiley \& Sons Inc.",

number = "1",

}

TY - JOUR

T1 - Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

AU - Ross, Owen A.

AU - Wu, Yih Ru

AU - Lee, Mei Ching

AU - Funayama, Manabu

AU - Chen, Meng Ling

AU - Soto, Alexandra I.

AU - Mata, Ignacio F.

AU - Lee-Chen, Guey Jen

AU - Chiung, Mei Chen

AU - Tang, Michelle

AU - Zhao, Yi

AU - Hattori, Nobutaka

AU - Farrer, Matthew J.

AU - Tan, Eng King

AU - Wu, Ruey Meei

PY - 2008/7

Y1 - 2008/7

N2 - Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LKRK2 variants in sporadic Parkinson's disease.

AB - Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LKRK2 variants in sporadic Parkinson's disease.

UR - https://www.scopus.com/pages/publications/48949092066

UR - https://www.scopus.com/pages/publications/48949092066#tab=citedBy

U2 - 10.1002/ana.21405

DO - 10.1002/ana.21405

M3 - Article

C2 - 18412265

AN - SCOPUS:48949092066

SN - 0364-5134

VL - 64

SP - 88

EP - 92

JO - Annals of Neurology

JF - Annals of Neurology

IS - 1

ER -

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this